Weiss Multi-Strategy Advisers’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,313	Closed	-$38K	–	674
2016 Q4	$38K	Hold	7,313	–	–	﹤0.01%	402
2016 Q3	$184K	Sell	7,313 -205	-3%	-$5.17K	0.01%	399
2016 Q2	$186K	Sell	7,518 -5,107	-40%	-$144K	0.01%	379
2016 Q1	$366K	Hold	12,625	–	–	0.02%	404
2015 Q4	$469K	Hold	12,625	–	–	0.03%	308
2015 Q3	$615K	Buy	12,625 +125	+1%	+$8.73K	0.03%	308
2015 Q2	$862K	Sell	12,500 -1,250	-9%	-$57.9K	0.03%	328
2015 Q1	$492K	Sell	13,750 -12,500	-48%	-$370K	0.02%	369
2014 Q4	$332K	Hold	26,250	–	–	0.01%	359
2014 Q3	$403K	Hold	26,250	–	–	0.01%	451
2014 Q2	$712K	Hold	26,250	–	–	0.02%	464
2014 Q1	$704K	Hold	26,250	–	–	0.01%	559
2013 Q4	$645K	Hold	26,250	–	–	0.01%	544
2013 Q3	$844K	Buy	+26,250	New	+$814K	0.02%	439

Other funds holding ANTH

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ANTH Position: Q1 2017 in Review

Weiss Multi-Strategy Advisers sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2017, closing a stake of 7,313 shares — an estimated $38K sold.

Weiss Multi-Strategy Advisers first reported a position in ANTH in Q3 2013 and held it in 14 quarters. The position peaked at $862K in Q2 2015. 60 funds tracked by Wall St. Rank hold ANTH as of Q1 2017.

Weiss Multi-Strategy Advisers reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 7,313 Anthera Pharmaceuticals, Inc. shares in Q1 2017, an estimated $38K.
Weiss Multi-Strategy Advisers first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2013 and held it in 14 quarters.
Weiss Multi-Strategy Advisers's Anthera Pharmaceuticals, Inc. position peaked at $862K in Q2 2015.
60 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2017, filed 15 May 2017.